Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

[18F] Fluorodeprenyl-D2 PET Imaging of Reactive Astrocytes as Chronic Active Inflammation Marker in Multiple Sclerosis

NCT07805473 is registered in ClinicalTrials.gov with Parc de Salut Mar as lead sponsor.

NCT NCT07805473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07805473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
[18F] Fluorodeprenyl-D2 PET Imaging of Reactive Astrocytes as Chronic Active Inflammation Marker in Multiple Sclerosis
Lead sponsor
Parc de Salut Mar
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 1, 2026
Completion date
December 1, 2029
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis